Robuta

https://pubmed.ncbi.nlm.nih.gov/38184107/
Immunocompromised patients with hematologic malignancies, particularly those treated with anti-CD20 antibodies such as rituximab and obinutuzumab, are known to...
acalculous cholecystitisacutefollowingextendedadministration